All Stories

  1. Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2023, New England Journal of Medicine (NEJM/MMS)

    Dr William J Muller

  2. Metronidazole for treatment of norovirus in pediatric transplant recipients

    Article • Pediatric Transplantation, September 2022, Wiley

    Dr William J Muller

  3. Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study

    Article • Journal of the Pediatric Infectious Diseases Society, August 2022, Oxford University Press (OUP)

    Dr William J Muller

  4. Live virus vaccination following pediatric liver transplantation: Outcomes from two academic children’s hospitals

    Article • Arabian archaeology and epigraphy, April 2022, Elsevier

    Dr William J Muller

  5. Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control

    Article • Communications Medicine, March 2022, Springer Science + Business Media

    Dr William J Muller

  6. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2022, New England Journal of Medicine (NEJM/MMS)

    Dr William J Muller

  7. SARS-CoV-2 Infection in Infants Less than 90 Days Old

    Article • The Journal of Pediatrics, September 2020, Elsevier

    Dr William J Muller

  8. Return to School for Pediatric Solid Organ Transplant Recipients in the United States During the Coronavirus Disease 2019 Pandemic: Expert Opinion on Key Considerations and Best Practices

    Article • Journal of the Pediatric Infectious Diseases Society, August 2020, Oxford University Press (OUP)

    Dr William J Muller

  9. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)

    Article • JAMA Pediatrics, July 2020, American Medical Association (AMA)

    Dr William J Muller

  10. Benign course of SARS‐CoV‐2 infection in a series of pediatric oncology patients

    Article • Pediatric Blood & Cancer, June 2020, Wiley

    Dr William J Muller

  11. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19)

    Article • Clinical Infectious Diseases, April 2020, Oxford University Press (OUP)

    Dr William J Muller

  12. Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy

    Article • Journal of Pharmacokinetics and Pharmacodynamics, April 2020, Springer Science + Business Media

    Dr William J Muller

  13. Utility of Metagenomic Next-generation Sequencing of Plasma for Infectious Pathogens

    Article • Clinical Infectious Diseases, March 2020, Oxford University Press (OUP)

    Dr William J Muller

  14. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children

    Article • Transplant Infectious Disease, August 2019, Wiley

    Dr William J Muller

  15. Lessons about early neurodevelopment in children exposed to ZIKV in utero

    Article • Nature Reports Stem Cells, July 2019, Springer Science + Business Media

    Dr William J Muller

  16. Non-invasive diagnosis of infection using plasma next-generation sequencing: A single center experience

    Article • Open Forum Infectious Diseases, July 2019, Oxford University Press (OUP)

    Dr William J Muller

  17. Cell‐free DNA next‐generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease

    Article • Pediatric Blood & Cancer, April 2019, Wiley

    Dr William J Muller

  18. Laboratory Diagnosis of Neonatal Herpes Simplex Virus Infections

    Article • Journal of Clinical Microbiology, January 2019, ASM Journals

    Dr William J Muller

  19. Outcomes of observation without empiric intravenous antibiotics in febrile, nonneutropenic pediatric oncology patients

    Article • Pediatric Blood & Cancer, November 2018, Wiley

    Dr William J Muller

  20. Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis

    Article • Infectious Disease Clinics of North America, March 2018, Elsevier

    Dr William J Muller

  21. Zika Virus: A Review for Pediatricians

    Article • Pediatric Annals, November 2017, SLACK, Inc.

    Dr William J Muller

  22. Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage

    Article • Scientific Reports, March 2017, Nature

    Dr William J Muller

  23. Preliminary Results From the US Zika Pregnancy Registry

    Article • JAMA, January 2017, American Medical Association (AMA)

    Dr William J Muller

  24. Treatment of perinatal viral infections to improve neurologic outcomes

    Article • Pediatric Research, September 2016, Nature

    Dr William J Muller

  25. IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients

    Article • British Journal of Pharmacology, May 2016, Nature

    Dr William J Muller

  26. The Type I Interferon Response Determines Differences in Choroid Plexus Susceptibility between Newborns and Adults in Herpes Simplex Virus Encephalitis

    Article • mBio, April 2016, ASM Journals

    Dr William J Muller

  27. HSV targeting of the host phosphatase PP1α is required for disseminated disease in the neonate and contributes to pathogenesis in the brain

    Article • Proceedings of the National Academy of Sciences, November 2015, Proceedings of the National Academy of Sciences

    Dr William J Muller

  28. Aspergillusthyroiditis: first antemortem case diagnosed by fine-needle aspiration culture in a pediatric stem cell transplant patient

    Article • Transplant Infectious Disease, October 2015, Wiley

    Dr William J Muller

  29. Differential Reliance on Autophagy for Protection from HSV Encephalitis between Newborns and Adults

    Article • PLoS Pathogens, January 2015, PLOS

    Dr William J Muller

  30. Early viral suppression improves neurocognitive outcomes in HIV-infected children

    Article • AIDS, January 2015, Wolters Kluwer Health

    Dr William J Muller

  31. Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT

    Article • Molecular Immunology, November 2014, Elsevier

    Dr William J Muller

  32. Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV

    Article • Pediatric Research, September 2014, Springer Science + Business Media

    Dr William J Muller

  33. Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy

    Article • Reviews in Medical Virology, May 2014, Wiley

    Dr William J Muller

  34. The Immunologic Basis for Severe Neonatal Herpes Disease and Potential Strategies for Therapeutic Intervention

    Article • Clinical and Developmental Immunology, January 2013, Hindawi Publishing Corporation

    Dr William J Muller

  35. Pathogenesis of Neonatal Herpes Simplex 2 Disease in a Mouse Model Is Dependent on Entry Receptor Expression and Route of Inoculation

    Article • Journal of Virology, October 2012, ASM Journals

    Dr William J Muller

  36. Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With Resistance

    Article • Journal of the Pediatric Infectious Diseases Society, May 2012, Oxford University Press (OUP)

    Dr William J Muller

  37. Herpes Simplex Virus-2 Glycoprotein Interaction with HVEM Influences Virus-Specific Recall Cellular Responses at the Mucosa

    Article • Clinical and Developmental Immunology, January 2012, Hindawi Publishing Corporation

    Dr William J Muller

  38. Functional Interaction between Herpes Simplex Virus Type 2 gD and HVEM Transiently Dampens Local Chemokine Production after Murine Mucosal Infection

    Article • PLOS One, January 2011, PLOS

    Dr William J Muller

  39. Immunobiology of Herpes Simplex Virus and Cytomegalovirus Infections of the Fetus and Newborn

    Article • Current Immunology Reviews, February 2010, Bentham Science Publishers

    Dr William J Muller

  40. Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection

    Article • Journal of General Virology, March 2009, Society for General Microbiology

    Dr William J Muller

  41. Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2

    Article • Archives of Virology, April 2008, Springer Science + Business Media

    Dr William J Muller

  42. Clinical and In Vitro Evaluation of Cidofovir for Treatment of Adenovirus Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients

    Article • Clinical Infectious Diseases, December 2005, Oxford University Press (OUP)

    Dr William J Muller

  43. Group Aβ-hemolytic Streptococcal Vulvovaginitis: Diagnosis by Rapid Antigen Testing

    Article • Clinical Pediatrics, March 2004, SAGE Publications

    Dr William J Muller

  44. A Strategy for the Evaluation of Sensory and Pulmonary Irritation Due to Chemical Emissions from Indoor Sources

    Article • Journal of the Air & Waste Management Association, September 1996, Taylor & Francis

    Dr William J Muller

  45. Sensory Irritation in Mice Exposed to Emissions from Indoor Products

    Article • AIHAJ, August 1995, Taylor & Francis

    Dr William J Muller

  46. Pathways for uptake of fluorescently labeled liposomes by alveolar type II cells in culture

    Article • AJP Lung Cellular and Molecular Physiology, July 1995, American Physiological Society

    Dr William J Muller

  47. A Model of Cigarette Smoke Particle Deposition

    Article • AIHAJ, May 1990, Taylor & Francis

    Dr William J Muller

  48. Studies of wall shear and mass transfer in a large scale model of neonatal high-frequency jet ventilation

    Article • Annals of Biomedical Engineering, January 1990, Springer Science + Business Media

    Dr William J Muller

  49. Airway deposition of hygroscopic heterodispersed aerosols: results of a computer calculation

    Article • Journal of Applied Physiology, September 1987, American Physiological Society

    Dr William J Muller